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Edited by Lukas HuberAbstract Triterpenoids are known to induce apoptosis and to be
anti-tumoural. Maslinic acid, a pentacyclic triterpene, is present
in high concentrations in olive pomace. This study examines the
response of HT29 and Caco-2 colon-cancer cell lines to maslinic-
acid treatment. At concentrations inhibiting cell growth by 50–
80% (IC50HT29 = 61 ± 1 lM, IC80HT29 = 76 ± 1 lM and
IC50Caco-2 = 85 ± 5 lM, IC80Caco-2 = 116 ± 5 lM), masli-
nic acid induced strong G0/G1 cell-cycle arrest and DNA frag-
mentation, and increased caspase-3 activity. However, maslinic
acid did not alter the cell cycle or induce apoptosis in the non-
tumoural intestine cell lines IEC-6 and IEC-18. Moreover,
maslinic acid induced cell diﬀerentiation in colon adenocarci-
noma cells. These ﬁndings support a role for maslinic acid as a
tumour suppressant and as a possible new therapeutic tool for
aberrant cell proliferation in the colon. In this report, we demon-
strate for the ﬁrst time that, in tumoural cancer cells, maslinic
acid exerts a signiﬁcant anti-proliferation eﬀect by inducing an
apoptotic process characterized by caspase-3 activation by a
p53-independent mechanism, which occurs via mitochondrial dis-
turbances and cytochrome c release.
 2006 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Currently, about one-fourth of all medications contain an
active ingredient derived from plants. Pentacyclic triterpenes,
biosynthesised in plants by squalene cycling, have been used
for more than 2000 years in traditional Asiatic medicine as
anti-inﬂammatory and anti-carcinogenic agents. Moreover,
their beneﬁcial eﬀects have been analysed by extensive preclin-
ical and epidemiological studies [1–4]. Some natural triterpe-
noids such as oleanolic, betulinic and ursolic acids have
shown notable eﬀects in suppressing tumourigenesis as well
as inhibiting tumours [1,5–9]. Also, a range of newly developedAbbreviations: FACS, ﬂuorescence-activated cell sorter; MTT, 3-(4,5-
dimethylthiazol-2yl)-2,5,-diphenyltetrazolium bromide; PI, propidium
iodide
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doi:10.1016/j.febslet.2006.10.038synthetic triterpenoids are more potent than the naturally
occurring parent structure [10,11]. In addition, several of these
compounds induce apoptosis in a wide variety of cancer cells,
including breast carcinoma, melanoma, hepatoma, prostate
carcinoma and acute myelogenous leukaemia [7]. To identify
potential new anticancer compounds, several pharmaceutical
companies are currently evaluating extracts from plants,
among these new natural triterpenoids and their derivatives
[12–14].
Olives are a rich source of pentacyclic triterpenes such as ole-
anolic and maslinic acids. Maslinic acid is also the main com-
ponent of protective wax-like coatings of olives. Researchers
have recently sought to characterize oleanolic acid and its
derivatives, which present strong anti-tumoural properties
[10,11,13,14]. The natural triterpenoid maslinic acid (Fig. 1),
which accounts for 80% of the wax in the olive skin, has also
been isolated and found to be a antioxidant [15], although its
properties as an anti-tumour agent have not yet been de-
scribed. In this paper, we assess the anticancer properties of
maslinic acid isolated from olive pomace. Maslinic acid has
potent diﬀerentiating and anti-proliferation properties in
colon-cancer lines, inducing cell-cycle arrest in the G0 phase
and apoptosis, through caspase activation, in these cells, but
not in normal intestinal cell lines. Apoptosis or programmed
cell death is deﬁned as an active physiological process of cell
self-destruction, with speciﬁc morphological and biochemical
changes in the nucleus and cytoplasm. Apoptotic death is
known to involve a cascade of proteolytic events driven mainly
by family of cysteine proteases such as caspase-3, the major
executioner of apoptosis. Agents that suppress the prolifera-
tion of malignant cells, by inducing apoptosis, may represent
a useful mechanistic approach to both chemoprevention and
chemotherapy of cancer. Due to these eﬀects, maslinic acid iso-
lated from olive pelt may provide a useful new therapeutic
strategy for colon carcinoma.2. Materials and methods
Dulbecco’s modiﬁed Eagle’s medium (DMEM, Sigma, St. Louis,
MO, USA), foetal bovine serum (FCS, Gibco-BRL, Eggenstein, Ger-
many), penicillin/streptomycin (Gibco-BRL, Eggenstein, Germany),
phosphate buﬀer saline (PBS, Sigma, St. Louis, MO, USA), 3-(4,5-
dimethylthiazol-2yl)-2,5,-diphenyltetrazolium bromide (MTT, Sigma,
St. Louis, MO, USA), dimethylsulfoxide (DMSO, Sigma, St. Louis,
MO, USA), Hoechst (Sigma, St. Louis, MO, USA), mowiol (Calbio-
chem, Merck, Darmstadt, Germany), annexin V-FICT (Bender Med-blished by Elsevier B.V. All rights reserved.
Fig. 1. Structure of maslinic acid. ((2a,3b)-2,3-dihydroxyolean-12-en-
28-oic acid. IUPAC name: 10,11-dihydroxy-2,2,6a,6b,9,9,12a-hepta-
methyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-car-
boxylic acid).
F.J. Reyes et al. / FEBS Letters 580 (2006) 6302–6310 6303Systems, Vienna, Austria), propidium iodide (PI, Sigma, St. Louis,
MO, USA), culture ﬂasks and well-plates (Techno Plastic Products,
Trasadingen, Switzerland).
2.1. Drugs
Maslinic acid, a natural hydroxyl pentacyclic derivative from
pressed olive (Olea europaea) fruits, is obtained from olive pomace,
using the method described in patent number PCT/ES97/000190. Its
molecular weight is 472.7. The extract used is a chemically pure white
powder comprising 98% maslinic acid and is stable when stored at
4 C. Maslinic acid was dissolved before use at 10 mg/ml in 50%
DMSO and 50% PBS. Stock solution was frozen and stored at
20 C. For treatments, this solution was diluted in cell culture
medium.
2.2. Cell culture
Human colorectal adenocarcinoma cell lines HT29 (ECACC no.
91072201) and Caco-2, (ECACC no. 86010202), as well as normal
mammalian intestinal cell lines IEC-6 (ECACC no. 88071401) and
IEC-18 (ECACC no. 88011801) (all cell lines used were provided by
the cell bank of the University of Granada, Spain) were cultured in
DMEM, supplemented with 2 mM glutamine, 10% heat-inactivated
FCS, 10000 units/ml of penicillin, and 10 mg/ml of streptomycin. Sub-
conﬂuent monolayers of cells were used in all experiments. In the fol-
lowing some relevant characteristics of this cell lines are summarized.
HT29 cells were isolated from a colon cancer of a 44 years old Cau-
casian female. These cells are a common cell line used in colon cancer
cells studies. Their tumorgenic capacity has been shown in nude mice,
they form well diﬀerentiated adenocarcinoma consistent with colonic
primary (grade I); and they also form tumors in steroid treated ham-
sters. This cell line is positive for the expression of: myc+, ras+,
myb+, fos+, p53+, abl, ros, src (ATCC: HTB-38). Doubling time
is around 48 h in normal culture conditions.
Caco-2 cells were isolated from a colon cancer of a 72 years old Cau-
casian male. Their tumorgenic capacity has been shown in nude mice,
they form moderately well diﬀerentiated adenocarcinome consistent
with primary colon (grade II). When reaching conﬂuence, cells express
enterocyte diﬀerentiation characteristics. Doubling time is around
62 h. (ATCC: HTB-37). The line is positive for expression of onco-
genes: p53, ras+, myc+, TGF b, TGF a+.
The two cells lines not present signiﬁcative diﬀerentiation at the level
of DNAmismatch proteins as describes in [16,17]. Respect to oxidative
damages both cellular lines present the similarity resistance to H2O2
citotoxicity [17], and similar antioxidants enzyme activity like glutathi-
one peroxidase [18].
The rat intestinal epithelial cell line (IEC-6) was originally described
as an homogenous population of epithelial-like cells with large, oval
nuclei, growing as tight colonies of polygonal, closely opposed cells
[19,20]. Ultrastructural characteristics include: microvilli in a perinu-
clear region; numerous mitochondria; a junctional complex; microﬁla-
ments especially prominent near the cell surface and sites of cell–cell
contact. All these features are consistent with those of intestinal crypt
cells. Since the establishment and characterization of this cell line, IEC-
6 cells have been used in numerous studies to elucidate mechanisms of
diﬀerentiation [21,22].IEC-18 cells, a cell line derived from the rat intestinal ileum, have
normal cells’ characteristics, since they have a contact inhibited cell
growth, do not form colonies in soft agar and are not tumorigenic
when injected in nude mice. IEC-18 has normal rat diploid kariotype,
a similar growth rate and surface antigens to intestinal epithelial cell
in vivo [19,23]. IEC-6 and IEC-18 cells express characterised antigens
from intestinal epithelia, these cells line have been qualiﬁed as normal
intestinal cells or non-transformed intestinal cells in numerous papers
[22,24–28].
Human colorectal adenocarcinoma cell lines HT29 (ECACC no.
91072201) and Caco-2, (ECACC no. 86010202), as well as normal
mammalian intestinal cell lines IEC-6 (ECACC no. 88071401) and
IEC-18 (ECACC no. 88011801) (all cell lines used were provided by
the cell bank of the University of Granada, Spain) were cultured in
DMEM, supplemented with 2 mM glutamine, 10% heat-inactivated
FCS, 10000 units/ml of penicillin, and 10 mg/ml of streptomycin. Sub-
conﬂuent monolayers of cells were used in all experiments.2.3. MTT assay
Cell viability was determined by measuring the absorbance of MTT
dye staining of living cells, as described elsewhere [29]. For this assay,
6 · 103 HT29 cells/well and 15 · 103 Caco-2 cells/well were cultured on
96 well plates.
Concentrations that inhibited cell growth by 50% (IC50) and 80%
(IC80) after 72 h of treatment were calculated based on the survival rate
compared with untreated cells. Relative cell viability was measured by
the absorbance on an ELISA plate reader (Tecan Sunrise MR20-301,
TECAN, Austria) at 550 nm.2.4. Hoechst-stained
The morphological changes were analysed by ﬂuorescent micros-
copy using Hoechst staining. For this, 175 · 103 HT29 cells/well and
4 · 105 cells/well were plated in 6 well plates. After 24 h maslinic acid
was added and the cells were incubated for 24, 48 and 72 h at their
respective IC80 values obtained at 72 h. Then the cells were washed
twice with PBS and harvested by tripsinization The cells were resus-
pended in 100% MetOH cold for 3 min. Afterwards, cells were washed
in PBS and incubated in 500 lL of Hoechst solution 50 ng/mL in PBS
for 15 min in darkness. The samples were prepared with mounting
medium mowiol and visualized by ﬂuorescent microscopy (DMRB,
Leica Microsystems, Wetzlar, Germany) with a DAPI ﬁlter.2.5. Cell-cycle analysis
The cell cycle was analysed with ﬂow cytometry by using a ﬂuores-
cence-activated cell sorter (FACS) at 488 nm in an Epics XL ﬂow
cytometer (Coulter Corporation, Hialeah, FL, USA), as described pre-
viously [30]. For this assay 175 · 103 HT29 cells/well, 4 · 105 Caco-2
cells/well, 150 · 103 IEC-6 cells/well and 50 · 103 IEC-18 cells/wells
were plated in 6 well plates with 2 ml of medium. After 24 h, maslinic
acid was added and the cells were incubated for 72 h with maslinic
acid. Maslinic acid doses used were the respective IC50 and IC80 val-
ues for the tumoral cell lines. IEC-6 and IEC-8 cells were incubated
with maslinic acid concentrations corresponding to the IC50 and
IC80 determined for HT29 cells at 72 h. In addition, HT29 cells were
incubated with their IC50 and IC80 concentrations for 96 h to observe
the appearance of subG0 peaks. All experiments were performed ﬁve
times with two replicates per experiment.
2.6. Annexin V-FITC binding assay
The same numbers of HT29, Caco-2, IEC-6 and IEC-18 cells as in
the cell-cycle assay were treated with maslinic acid, as described above.
Cells were collected and resuspended in binding buﬀer (10 mM
HEPES/NaOH, pH 7.4, 140 mM NaCl, 2.5 mM CaCl2). Annexin V-
FITC conjugate (1 lg/ml) was added and incubated for 30 min at room
temperature in darkness. Just before FACS analysis, cells were stained
with 20 lL of 1 mg/ml PI solution. In each experiment, approximately
20 · 103 cells were analysed and the experiment was performed ﬁve
times.
2.7. Assay for Caspase-3 protease
Caspase-3 activity was measured using a colorimetric assay (caspase-
3 colorimetric assay kit, Sigma, St. Louis, MO, USA) based on
the hydrolysis of the peptide substrate acetyl-Asp-Glu-Val-Asp
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of the p-nitroanyline. In short, 1.2 · 106 HT29 cells/well and 2.7 · 106
Caco-2 cells/well were cultured in 100-mm plates and were treated for
72 h with maslinic acid at their IC50 and IC80 concentrations. Cells
were lysed with lysis buﬀer (50 mM HEPES, pH 7.4, 5 mM Chaps,
5 mM dithiothreitol) for 20 min on ice, and cell lysates were diluted
with the assay buﬀer (20 mM HEPES, pH 7.4, 0.1% Chaps, 5 mM
dithiothreitol, 2 mM EDTA) containing 0.2 mM of caspase-3 sub-
strate. The p-nitroanyline concentration was determined by the absor-
bance measured at 405 nm using an ELISA reader.
2.8. DNA fragmentation analysis
The same numbers of HT29 and Caco-2 cells as for the caspase-3 as-
say were treated with maslinic acid. Chromosomal DNA was isolated
using a real pure extraction kit (Real, Durviz, Valencia, Spain) and
ladder-formation assays were made as described previously [18,31].
This assay was performed four times in both cell types.
2.9. Preparation of cytosolic extracts for cytochrome c analysis
HT29 cells (1.2 · 106) were cultured in 100-mm plates and were trea-
ted for 48 and 72 h with maslinic acid at its IC50 concentrations. After
treatment, HT29 cells were washed with ice-cold PBS and resuspended
in ice-cold lysis buﬀer (20 mM HEPES–KOH, pH 7.5, 10 mM KCl,
1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 250 mM sucrose,
1 mM dithiothreitol, 0.1 mM phenyl methylsulfonyl ﬂuoride, 1 lg/ml
of pepstatin A, 2 lg/ml of leupeptin and 10 lg/ml of aprotinine). After
incubation on ice for 30 min, cells were homogenized with 15 strokes of
pre chilled pestle B homogenizer (Sigma, St Louis, MO, USA), and the
homogenates were centrifuged at 25000 · g for 30 min at 4 C. Super-
natants were further centrifuged at 25000 · g for 30 min at 4 C and
stored at 80 C for cytochrome c analysis.
2.10. Western blotting
HT29 cells (1.2 · 106) were treated with maslinic acid at their IC50
values of concentration for 48 and72 h. Caco-2 cells (2.7 · 106) were
treated at their IC50 value for 6 and 12 h. Non-cancer cells IEC-6
(1.0 · 106) and IEC-18 (3.0 · 106) were treated at HT29 cells’ IC50
for 6, 12, 48 and 72 h. After treatment, the cells were washed twice with
PBS and resuspended in lysis buﬀer (20 M Tris/acetate, pH 7.5,
270 mM sucrose, 1 mM EDTA, pH 8.8, 1 mM EGTA, pH 8.8, 1% Tri-
ton X-100, 1 mM ortovanadate, 1 mM sodium glycerophosphate,
5 mM sodium ﬂuoride, 1 mM sodium pyrophosphate, 5 mM b-
mercaptoethanol, 1 mM benzamidine, 34.8 lg/ml PMSF, 5 lg/ml leu-
peptine). The samples, homogenized by ultrasonic and incubated on
ice for 20 min, were then centrifuged at 12000 · g for 15 min, and
supernatants were assayed for protein concentration using BCA kit
(Pierce Biotechnology, Rockford, USA).
For the Western-blot analysis, 50 lg of proteins were loaded on a
15% SDS–polyacrylamide gel and transferred to a polyvinyl nitrocellu-
lose transfer membrane (Bio-Rad Laboratories, Richmond, C, USA).
The membranes were blocked by incubation in TBS buﬀer containingFig. 2. Growth-inhibitory eﬀects of maslinic acid on HT29 and Caco-2 c
concentration of maslinic acid indicated for 72 h. Cell-growth inhibition was a
of the individual cell lines. The assay was done using six replicates and repe0.1% of Tween and 5% of dry milk for 1 h at room temperature and
washed 3 times with TBS buﬀer of 0.1% Tween. Then membranes were
blotted overnight at 4 C with primary antibodies rabbit polyclonal
anti-caspase 3 (1/1000, Cell Signalling Technology, Danvers, USA).
For cytochrome c determination, membranes were blotted for 1 h at
25 C with a mouse monoclonal primary antibody anti-cytochrome c
(1/3000, BD Biosciences, Erembodegem, Belgium). The blots were
washed 3 times with TBS-0.1% Tween and developed with peroxi-
dase-linked secondary antibodies (1/3000, Santa Cruz Biotechnology,
California, USA). All blots were developed by ECL Western Blotting
Detection Kit Reagent (Amersham Biosciences, Freiburg, Germany)
and detected using LAS-3000 imaging system (Fuji Photo Film (Eur-
ope), TK Tilburg, The Netherlands).2.11. Alkaline phosphatase activity
Alkaline phosphatase activity was measured by p-nitrophenol for-
mation from p-nitrophenyl phosphate (Sigma, St. Louis, MO, USA).
For this assay 1.2 · 106 HT29 cells/well and 2.7 · 106 Caco-2 cells/well
were treated with maslinic acid at IC50 and half IC50 concentrations.
After incubation, HT29 and Caco-2 cells were collected by scraping.
Cells were broken with lysis buﬀer (20 mM Tris, pH 7.5, 1 mM
DTT, 1 mM EDTA, 0.2 g/L Triton X-100, 0.2 g/L of sodium deoxy-
cholate and 0.2 mM PMSF) and centrifuged at 100000 · g for 1 h at
4 C. Alkaline phosphatase activity was measured in the supernatants
as described previously [31].
2.12. Statistics
Data are given as the means ± S.E.M. For each assay, the Student’s
t test was used for statistical comparison with the untreated control
cells.3. Results
3.1. Maslinic acid inhibits colon adenocarcinoma cell
proliferation
We examined the eﬀect of maslinic acid on the proliferation
of HT29 and Caco-2 adenocarcinoma cell lines using the MTT
assay. HT29 and Caco-2 cells were treated with increasing
doses of maslinic acid; their viability was determined by forma-
zan dye uptake and expressed as percent of untreated control
cell proliferation. Maslinic acid induced a dose-dependent de-
crease in viable formazan accumulating cells after 72 h of treat-
ment, ranging from 0 to 120 lM (Fig. 2). Concentrations of
maslinic acid required for 50% growth inhibition (IC50) were
61 ± 1 lM for HT29 and 85 ± 5 lM for Caco-2 cells and for
80% growth inhibition (IC80) were 76 ± 1 lM for HT29 andolon cancer cells. Exponentially growing cells were treated with the
nalysed by the MTT assay, as described in Section 2. Inset, IC50 values
ated eight times. Points, means ± S.E.
Table 1
Cell-cycle analysis of maslinic acid-treated cells
Cell line Maslinic (lM) Phase of cell cycle (% of cells)
G0/G1 S G2/M
HT29 0 62 ± 5 30 ± 6 8 ± 3
61 75 ± 5** 20 ± 4** 4 ± 4*
76 84 ± 6** 12 ± 6** 4 ± 1**
Caco-2 0 76 ± 12 21 ± 9 5 ± 4
85 89 ± 5** 9 ± 5** 2 ± 1*
116 87 ± 3* 6 ± 5** 7 ± 5
IEC-6 0 68 ± 6 12 ± 4 20 ± 5
61 69 ± 6 9 ± 4 21 ± 3
76 70 ± 2 9 ± 2 21 ± 3
IEC-18 0 77 ± 9 10 ± 2 13 ± 7
61 80 ± 10 10 ± 2 11 ± 8
76 82 ± 5 10 ± 2 8 ± 3
HT29 and Caco-2 cells were untreated (ﬁrst value) or treated with
maslinic acid at their IC50 (second value) or IC80 (third value) con-
centrations. IEC-6 and IEC-18 were treated with concentrations of
IC50 and IC80 for HT29 cells. All cell lines were treated for 72 h at
37 C. Cell-cycle analysis was conducted after propidium iodide
staining, as described in Section 2. Values represent means ± S.E. of
seven independent experiments. Key (*) P < 0.05, (**) P < 0.01, with
respect to the untreated cells.
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of maslinic acid found for HT29 after 72 h of incubation the
survival rates of IEC-6 were 78% at IC50 and 63% at IC80,
and those of IEC-18 were 68% at IC50 and 62% at IC80.
3.2. Maslinic acid induces morphological changes
The Hoechst procedure stains nuclei that contain nicked
DNA, a characteristic exhibited by cells in apoptotic cell
death. Morphological analysis of Hoechst-stained cells, in
HT29 and Caco-2 cells, indicated that they had undergone
remarkable morphological changes (Fig. 3). After 48 h expo-
sure to maslinic acid at IC80 concentration, the cells showed
typical apoptotics changes, including cell shrinkage, chromatin
condensation, and loss of normal nuclear architecture. At 72 h
of incubation the disruption of cell-membrane integrity was
more prominent. Fluorescence microscopic observation after
Hoechst staining showed that a relevant number of cells trea-
ted with maslinic acid acquired apoptotic features, as evident
from nuclear fragmentation.
3.3. Maslinic acid induces cell-cycle arrest and apoptosis
HT29 and Caco-2 cells treated with maslinic acid at IC50
and IC80 concentrations showed a signiﬁcant increase in the
population in G0/G1 phases (increases of 13% for HT29 and
13% for Caco-2 at IC50, and of 22% for HT29 and 11% for
Caco-2 at IC80) with a concomitant decrease in the percentage
of cells in the S phase (10% for HT29 and 12% for Caco-2 atFig. 3. Morphology changes in colon cancer cells. Morphology of HT29 (A) a
ﬂuorescence microscopy after Hoechst staining at 24, 48 and 72 h of treatmIC50, and 18% for HT29 and 15% for Caco-2 at IC80) with re-
spect to untreated cells, suggesting G0/G1 arrest (Table 1).nd Caco-2 (B) cells after exposure to maslinic acid was examined using
ent.
Fig. 5. Maslinic-acid-induced apoptosis through activation of caspase-
3. HT29 and Caco-2 cells were untreated (grey bars) or treated for 72 h
with their corresponding IC50 (black bars) or IC80 (white bars)
concentrations. Cell extracts were prepared and assayed for caspase-3
activity as described in Section 2. Values represent means ± S.E. of
seven experiments. Key (*) P < 0.05, (**) P < 0.01 with respect to the
untreated cells.
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HT29 cells in response to treatment with maslinic acid, indicat-
ing that cells underwent apoptosis. These results suggest that
maslinic acid induced cell-cycle arrest in HT29 and Caco-2
cells coinciding with apoptotic cell death. At these concentra-
tions of maslinic acid, no eﬀect was observed on the cell cycle
of the normal intestinal cell lines IEC-6 and IEC-18 (Table 1).
Assessment of apoptosis in HT29 and Caco-2 cells was per-
formed 72 h after treatment with maslinic acid at the concen-
trations mentioned above for the analysis of cell cycle.
FACS analysis using Annexin V-FITC staining and PI accu-
mulation was used to diﬀerentiate early apoptotic cells (Annex-
in V+ and PI) from late apoptotic/necrotic cells (Annexin V+
and PI+). In comparison with untreated controls, maslinic acid
treatment of HT29 cells generated apoptosis in 25% of cells at
a concentration of IC50 (14% early apoptosis and 11% late
apoptosis/necrosis) and in 38% of cells at IC80 (27% early
apoptosis plus 11% late apoptosis). In Caco-2 cells the percent-
age of apoptosis at IC50 was 14% (7% early apoptosis plus 7%
late apoptosis/necrosis) with respect to the untreated controls,
lower than in HT29, but at IC80 the rate increased dramati-
cally to 60% (15% early apoptosis plus 45% late apoptosis/
necrosis), due to a marked increase in the number of late apop-
totic cells (Fig. 4). At these concentrations of maslinic acid, no
eﬀect on apoptosis induction was observed in the normal intes-
tinal cell lines IEC-6 and IEC-18. Annexin-V binding assay
thus conﬁrmed the observation that maslinic acid induced both
cell-cycle arrest and apoptosis.
3.4. Involvement of caspase-3 in maslinic acid induced apoptosis
For a direct examination of the involvement of caspase-3 in
maslinic-acid-induced apoptosis, caspase-3 activity was deter-
mined in cells treated with maslinic acid for 72 h (at IC50
and IC80) using a colorimetric assay based on the hydrolytic
rupture of the peptide Ac-DEVD-pNA. As shown in Fig. 5,
maslinic acid caused a concentration-dependent activation of
caspase-3 in both HT29 and Caco-2 cells.
3.5. Maslinic acid induces DNA fragmentation
Internucleosomal DNA fragmentation in HT29 and Caco-2
cells induced by maslinic acid was detected by DNA ladder onFig. 4. Flow cytometry analysis of Annexin V-FITC staining and PI accumul
Cell lines were treated with maslinic acid at a concentration equal to its IC50 o
PI, whereas late apoptotic/necrotic cells (dark-grey bars) were Annexin V
duplicate. Key (*) P < 0.05, (**) P < 0.01, compared with the correspondingagarose gels. DNA extracted from HT29 and Caco-2 cells trea-
ted with maslinic acid for 72 h displayed a characteristic ladder
pattern of discontinuous DNA fragments on agarose-gel elec-
trophoresis at both IC50 and IC80, while untreated controls
did not (Fig. 6). The eﬀect of maslinic acid on DNA fragmen-
tation was similar in HT29 and Caco-2 cells.
3.6. Western blotting
To begin to address the mechanism by which maslinic acid
causes apoptosis, we ﬁrst examined whether caspase-3 protease
is involved in the cell death response in HT29 and Caco-2, and
in non-tumoural intestinal cells IEC-6 and IEC-18, for diﬀer-
ent incubation times. Caspase-3 activity signiﬁcantly increased
after 72 h of treatment (Fig. 5). Then we investigated whether
the apparent promotion of apoptosis by maslinic acid could beation after exposure of HT29 and Caco-2 cells to maslinic acid for 72 h.
r its IC80 values. Early apoptotic cells (light-grey bars) were Annexin V
+
+ PI+. Values are expressed as means ± S.E. of ﬁve experiments in
value in untreated cells.
Fig. 6. DNA fragmentation after exposure to maslinic acid. Both HT29 and Caco-2 cells were exposed for 72 h to their IC50 and IC80 concentrations.
Genomic DNA was extracted as described in Section 2, electrophoresed in a 1.5% agarose gel, and visualized with ethidium bromide staining.
Fig. 7. Caspase-3 induction in tumoural colon-cancer cells and in non-tumoural intestinal cells. Eﬀect of maslinic acid on caspase-3 activation in
non-tumoural cells IEC-6 and IEC-18 at 6, 12, 48, 72 h of treatment (A,B). Eﬀect on tumoural cells Caco-2 at 6, 12 h of treatment (C) and in HT29
cells after 48 and 72 h of treatment (D). In non-tumoural cells, no caspase-3 activation was observed, while Caco-2 cells showed early caspase-3
activation (6, 12 h), and in HT29 cells caspase-3 activation was very late (72 h).
Fig. 8. Cytochrome c induction in HT29 colon cancer cells. Eﬀect of
maslinic acid on cytosolic cytochrome c release in HT29 cells at 48 and
72 h of treatment. Cytosolic lysates were analysed by immunoblotting
with anti-cytochrome c, as described in Section 2.
F.J. Reyes et al. / FEBS Letters 580 (2006) 6302–6310 6307linked to a variation in caspase-3 expression at the diﬀerent
incubation times of 6, 12, 48 and 72 h (Fig. 7). At 6 or 12 h
of treatment, caspase-3 was activated in Caco-2 cells but not
in HT29 cells. In HT29 cells the caspase-3 activation at IC50
was very late (at 72 h of treatment), whereas in Caco-2 cells
this activation occurred early (at 6 h of treatment). In non-
tumoural cells IEC-6 and IEC-18, no eﬀect was detected on
caspase-3 activation at the maslinic-acid concentration used
for any of the times assayed.
In most cases the apoptosis involves a disruption of mito-
chondrial membrane integrity that is decisive for the cell-death
process. We next evaluated the eﬀects of maslinic acid on the
release of mitochondrial cytochrome c into the cytosol in
HT29 cells. Western-blot analysis, shown in Fig. 8, revealed
that the treatment of HT29 cells with its IC50 concentration
induce the release of mitochondrial cytochrome c into the cyto-
sol at 48 and 72 h. Taken together, these result lead us to con-
clude that the mitochondria plays an important role in theactivation of caspase-3 and in the induction of apoptosis trig-
gered by maslinic acid in colon carcinoma cells.
3.7. Maslinic acid induce increase in alkaline phosphatase
activity
To determine the diﬀerentiation eﬀect of the maslinic acid on
colon cancer cells we have quantiﬁed the alkaline phosphatase
activity before and after maslinic acid treatment. The increase
Fig. 9. Maslinic acid induced alkaline phosphatase activity. HT29 and
Caco-2 cells were untreated (grey bars) or treated for 72 h with their
corresponding IC50 (black bars) or half IC50 (white bars) concentra-
tions. Cell extracts were prepared and assayed for alkaline phosphatase
activity as described in Section 2. Values represent means ± S.E. of
four experiments. Key (*) P < 0.05, (**) P < 0.01 with respect to the
untreated cells.
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in colon cancer cells [32].
The result showed an increase in alkaline phosphatase activ-
ity in a dose-dependent way at 72 h, being higher at IC50 than
at half IC50 concentrations. In HT29 cells the increment was
of fourfold at IC50 concentrations, in Caco-2 cells this incre-
ment was twofold respect to the control untreated cells
(Fig. 9). This result along with the G0/G1 arrest indicates that
the maslinic acid produce cell diﬀerentiation eﬀects in colon
cancer cells.4. Discussion
Many modern anti-cancer drugs are secondary metabolites
with high bioactivity. Triterpenoids exert various pharmaco-
logical eﬀects to control many diseases, including cancer
[3,6,33–36]. The present study is the ﬁrst to evaluate the poten-
tial anti-tumoural eﬀects of maslinic acid, a new triterpenoid
isolated as a majority compound from olive-pelt pomace.
Our data provide evidence that maslinic acid exerts anti-prolif-
erative and pro-apoptotic eﬀects in HT29 and Caco-2 colon
adenocarcinoma cell lines. Moreover, maslinic acid induces
morphological changes that are characteristic of apoptosis,
such as chromatin condensation and fragmentation as well
as cell shrinkage, as demonstrated by ﬂuorescence microscopy.
Analysis of the mechanisms of maslinic-induced cell death
indicated activation of caspase-3 and DNA fragmentation,
suggesting apoptotic cell death. Quantiﬁcation of apoptosis
using annexin V-FITC and PI staining by FACS analysis
showed that the percentage of apoptotic cells at IC50 was low-
er in Caco-2 cells 14% ( 7% early apoptosis plus 7% late apop-
tosis/necrosis) than in HT29 cells 25% (14% early apoptosis
and 11% late apoptosis/necrosis); at IC80, however, it in-
creased dramatically and was even higher in Caco-2 cells
60% (15% early apoptosis plus 45% late apoptosis/necrosis)
than in HT29 cells 38% (27% early apoptosis plus 11% late
apoptosis), indicating that the activation of the apoptotic path-
way may occur more slowly in HT29 cells.In the process of diﬀerentiation, enterocytes acquire struc-
tural features of mature cells, express speciﬁc gene products
such as intestinal alkaline phosphatase and develop specialized
cellular functions [31]. This growth inhibition near to the cell
cycle arrest and the increase in alkaline phosphatase activity
are characteristics markers of enterocyte diﬀerentiation [32,37].
The fact that maslinic acid induces an stronger arrest in G0/
G1 and a higher increase in alkaline phosphatase in HT29 than
in CaCo-2 cells indicates that maslinic acid is a more potent in-
ducer of diﬀerentiation in HT29 cells than in CaCo-2 cells.
It is noteworthy that the eﬀect of maslinic acid on cell cycle
and apoptosis induction was selective for malignant cells, since
it did not alter the cell cycle or induce apoptosis in normal
intestine cell lines (IEC-6 and IEC-18). This eﬀect of maslinic
acid on pro-apoptotic pathways speciﬁc for malignant cells
means that this compound is of potential interest for cancer
patients. In conclusion, we show that maslinic acid selectively
induces the caspase apoptotic pathway in colon adenocarci-
noma cell lines, causing G0/G1 cell-cycle arrest.
Because caspases are speciﬁc proteases of apoptosis, and
among them more particularly caspase-3, we examined
whether the possible apoptotic eﬀect or maslinic acid on colon
carcinoma cells HT29 and Caco-2 could be linked to induction
of caspase-3. From 6 h of treatment, maslinic acid induced cas-
pase-3 activity only in Caco-2 cells. At 72 h of treatment masli-
nic acid stimulated caspase-3 activity in HT29 cells. As
caspase-3 activation is a phenomenon previous to the morpho-
logical changes reﬂected in the FACS analysis, this diﬀerence
in caspase-3 activation agreed with the results found in FACS
analysis, where HT29 cells showed a higher percentage of early
apoptosis at 72 h, a circumstance that could be explained by
the late activation of caspase-3 (72 h). Moreover, in the FACS
analysis, Caco-2 cells presented a very high percentage of late
apoptosis at 72 h of treatment, which could be correlated with
the early activation of caspase-3 (6 h).
In normal intestinal cells lines IEC-6 and IEC-18, caspase-3
activation was not detected. In addition, caspase-3 activation
is apparently time-dependent, this activity occurring prior to
the appearance of characteristic apoptotic morphological fea-
tures. Maslinic acid may thus be eﬀective as a selective apopto-
genic agent that exploits endogenous apoptosis-inducing
mechanisms as a potential mean of treating or preventing
colon adenocarcinoma. However, clinical trials will be
required for determining whether maslinic acid can be eﬀec-
tively used in the pharmacology treatment of cancer.
In many cancer cell lines, p53 expression may contribute to
therapeutic eﬃcacy of cytotoxic drug. Although it does not
seem to be necessary for induction of apoptosis in Caco-2 cells
(p53 deﬁcient) by maslinic acid, the cleavage of caspase-3 ap-
pears to correlate with maslinic-acid-induced apoptosis in both
the HT29 and Caco-2 cell lines. It has been demonstrated that
cytochrome c participates in the activation of caspase-3. These
data suggest a linear and speciﬁc activation of caspase-3 in re-
sponse to cytochrome c released from the mitochondria. Cyto-
chrome c normally resides in the mitochondrial intermembrane
space, where it serves a transducer of electrons in the respiratory
chain. Several anti-tumour drugs with diverse intracellular tar-
gets have been demonstrated to cause the mitochondrial release
and cytosolic accumulation of cytochrome and activation of
caspase-3 [38]. Although the mechanism is not yet fully under-
stood, the release of cytochrome c is considered to be a very
important event for the induction of apoptosis by maslinic acid.
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liferation and induces apoptosis of human colon carcinoma
cells. Exposure to maslinic acid resulted in the activation of
caspase-3 through the release of cytochrome c from the mito-
chondria. The more precise signalling pathway by which masli-
nic acid triggers caspase-3 activation, cytochrome c release,
and the other apoptotic phenomena described here remain to
be identiﬁed. Nevertheless, our data should contribute to the
development of maslinic acid or related drugs as potential can-
cer chemotherapeutic or chemopreventive agents.
Although the detailed mechanism by which maslinic acid in-
duces apoptosis remains still to be elucidated, it seems that this
compound modulates multiple factors that could increase cel-
lular susceptibility to apoptosis.
For example the over-expression of a mutated p53 in HT29
cells [39] could explain the cell cycle arrest, diﬀerentiation and
late caspase-3 induction obtained. In this case, maslinic acid
could induce the cell diﬀerentiation mediated by p53, previous
to the apoptosis activation. On an other hand, the fact that in
Caco-2 cells p53 gene has deleted and mutated alleles and no
detectable accumulation of the corresponding protein [21,40]
could explain the lowest diﬀerentiation and the early cas-
pase-3 activation obtained.
By the other hand, apoptosis induction could be due to a
receptor mechanism, this mechanism have been proposed by
diﬀerent authors in papers related with colon cancer cells
[41,42], a diﬀerent number of receptors in these cell lines could
explain the diﬀerential apoptosis induction by maslinic acid.
For example, it has been reported that many types of cancer
can use signals frommultiple growth factor receptor for growth
and survival [25,43]. The TGF receptors are intimately related
with MAP-kinases mediated apoptotic pathway (JNK, p53/
Erk), whereas p53 is activated in the endpoints of the pathway
[44–46]. The growth-inhibitory apoptotic potential and growth
factor-modulator eﬀects of maslinic acid could be related with
MAP-kinases mediated apoptotic pathway [22]. Other MAP-
kinases pathways as the TNF1a receptor-JNK-jBID pathway
could be related with apoptotic activation by maslinic acid
[47]. Further studies will be directed in this direction.
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